Back

Is steroid therapy really banned for lymphocytic myocarditis before excluding viral infection?

European Heart Journal

6 November 2018
Organised by: Logo
Read full article
ESC Journals VALVULAR, MYOCARDIAL, PERICARDIAL, PULMONARY, CONGENITAL HEART DISEASE Myocardial Disease

Contributors

Tsunenori Saito
Tsunenori Saito

Author

Cedars-Sinai Smidt Heart Institute Los Angeles , United States of America

Hironori Katayama
Hironori Katayama

Author

Eitaro Kodani
Eitaro Kodani

Author

You may be interested in
thumbnail
Congress Presentation
Results of personalized immunosupressive therapy in patients with chronic virus-negative and parvovirus-positive lymphocytic myocarditis
29 June 2021
thumbnail
Congress Presentation
Viral infections and atherosclerosis : a systematic literature review
25 April 2026
thumbnail
Congress Presentation
An uncommon cause of fulminant myocarditis: anabolic steroid–associated cardiac involvement
10 May 2026
thumbnail
Congress Presentation
Long time clinical course of cardiac sarcoidosis with corticosteroid therapy -from Japanese nationwide questionnaire survey-
1 September 2020

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources